JAZZ Latest Headlines

Jazz Pharmaceuticals: Buy Rating Supported by Strong Execution, Raised Outlook, and Unchanged $314 Price Target

at www.tipranks.com (Mon, 2-Nov 9:36 PM)

Jazz Pharmaceuticals Non-GAAP EPS of -$3.88 misses by $1.50, revenue of $1.24B beats by $30M

at seekingalpha.com (Mon, 2-Nov 4:23 PM)

Here are the major earnings after the close Monday

at seekingalpha.com (Mon, 2-Nov 9:00 AM)

Jazz Pharmaceuticals Q3 2026 Earnings Preview

at seekingalpha.com (Sun, 1-Nov 5:35 PM)

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Jazz Pharmaceuticals (JAZZ) and Repligen (RGEN)

at www.tipranks.com (Wed, 28-Oct 8:41 AM)